Supplementary_material: Prognostic significance and function of minichromosome maintenance protein 10 in human hepatocellular carcinoma.docx

<b>Supplementary
Figure 1</b>
<b>Data for MCM10
expression in HCC from online databases.</b> (<b>A</b>) The
transcription level of MCM10 in 20 different types of human cancers
(ONCOMINE). Color is determined by the highest gene rank percentile genes
based on log fold-change; red represents upregulation and blue indicates
downregulation. Cut-off of <i>P</i>-value and fold change were as following: <i>P</i>-value:
0.05, fold change: 1.5, gene rank: 10%, data type: mRNA. (<b>B</b>) Relative
expression of MCM10 in HCC tissues (n = 371) and adjacent normal liver
tissues (n = 50) from TCGA database (UALCAN). (<b>C</b>) Relative expression
of MCM10 in normal individuals (n = 50) and in HCC patients with different
cancer stages (Stage 1, n = 168; Stage 2, n = 84; Stage 3, n = 82; Stage 4, n
= 6). *<i>P</i> &lt; 0.05, **<i>P</i> &lt; 0.01, ***<i>P</i> &lt; 0.001. (<b>D</b>)
Representative immunohistochemistry images of MCM10 protein in HCC tissues
and normal liver tissues (Human Protein Atlas).
<b> </b>
<b>Supplementary Table 1 </b>
Clinicopathological
characteristics of 364 HCC patients.

<b>Supplementary Table
2 </b>
Estimated
AUC value of TNM and MCM10 in 364 HCC patients after follow-up.

<b>Supplementary Table
3 </b>
Summary
of significantly enriched GO annotations of MCM10 related network.